These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7921517)

  • 1. Pharmacodynamics of a continuous intravenous infusion of CGP-35126 recombinant human insulin-like growth factor-I (rhIGF-I) on glucose and insulin levels in healthy males.
    Morgan JM; Piraino AJ; Saris SD; Capuzzi DM
    Int J Clin Pharmacol Ther; 1994 May; 32(5):235-9. PubMed ID: 7921517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemic and insulin response to a continuous intravenous infusion of CGP-35126 recombinant human insulin-like growth factor-I (rhIGF-I) in healthy males.
    Morgan JM; Saris SD; Capuzzi DM; Good WR; John VA; Guler HP; Seaman J; Piraino AJ
    J Clin Pharmacol; 1993 Apr; 33(4):366-72. PubMed ID: 8473552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.
    Douglas RG; Gluckman PD; Ball K; Breier B; Shaw JH
    J Clin Invest; 1991 Aug; 88(2):614-22. PubMed ID: 1864971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
    Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
    Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
    Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
    Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].
    Kato M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):613-25. PubMed ID: 10036618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of insulin-like growth factor binding protein-2 as a biochemical surrogate marker for the in vivo effects of recombinant human insulin-like growth factor-1 in mice.
    Bhat RV; Engber TM; Zhu Y; Miller MS; Contreras PC
    J Pharmacol Exp Ther; 1997 Apr; 281(1):522-30. PubMed ID: 9103540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.
    Zenobi PD; Jaeggi-Groisman SE; Riesen WF; Røder ME; Froesch ER
    J Clin Invest; 1992 Dec; 90(6):2234-41. PubMed ID: 1469083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.
    Kerr D; Tamborlane WV; Rife F; Sherwin RS
    J Clin Invest; 1993 Jan; 91(1):141-7. PubMed ID: 8423214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.
    Chapman IM; Hartman ML; Pieper KS; Skiles EH; Pezzoli SS; Hintz RL; Thorner MO
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2836-42. PubMed ID: 9709956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of hypoglycemia in response to varying doses of recombinant human insulin-like growth factor-I (rhIGF-I) in children and adolescents with low serum concentrations of IGF-I.
    Guevara-Aguirre J; Guevara-Aguirre M; Rosenbloom AL
    Acta Paediatr; 2006 Feb; 95(2):199-202. PubMed ID: 16449027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
    Mauras N; Horber FF; Haymond MW
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R; Ninnis R; Keller U
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-1 stimulation of lymphopoiesis.
    Clark R; Strasser J; McCabe S; Robbins K; Jardieu P
    J Clin Invest; 1993 Aug; 92(2):540-8. PubMed ID: 8349796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect.
    Mauras N; Beaufrere B
    J Clin Endocrinol Metab; 1995 Mar; 80(3):869-74. PubMed ID: 7533772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.
    Hartman ML; Clayton PE; Johnson ML; Celniker A; Perlman AJ; Alberti KG; Thorner MO
    J Clin Invest; 1993 Jun; 91(6):2453-62. PubMed ID: 8514857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of free insulin-like growth factor-I in healthy subjects.
    Frystyk J; Hussain M; Skjaerbaek C; Pørksen N; Froesch ER; Orskov H
    Growth Horm IGF Res; 1999 Apr; 9(2):150-6. PubMed ID: 10373348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of insulin, insulin-like growth factor-I and growth hormone in counteracting dexamethasone induced nitrogen wasting in rats.
    Malmlöf K; Arrhenius-Nyberg V; Saxerholt H; Skottner A
    Horm Metab Res; 1997 Jan; 29(1):20-4. PubMed ID: 9049649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study.
    Hansen-Pupp I; Hellström A; Hamdani M; Tocoian A; Kreher NC; Ley D; Hallberg B
    Growth Horm IGF Res; 2017 Oct; 36():44-51. PubMed ID: 28934640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.
    Zenobi PD; Graf S; Ursprung H; Froesch ER
    J Clin Invest; 1992 Jun; 89(6):1908-13. PubMed ID: 1601998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.